Telomir Pharmaceuticals logo
Telomir Pharmaceuticals
TELO | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.01 (-2.08%)
At close: Nov 13, 2026, 4:00 PM ET
$0.50
+$0.01 (+2.45%)
After-hours: Nov 13, 2026, 7:30 PM ET

Telomir Pharmaceuticals Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
– – – – –
– – – – –
– – – – –
-10.54M -12.24M -3.94M -854.15K -138.13K
125.64K 48K – – –
-10.41M -16.53M -13.07M -854.15K -138.13K
-10.41M -16.53M -13.07M -854.15K -138.13K
8.1M 9.64M 600.19K 20.94K 11.64K
2.44M 2.24M 1.57M 833.21K 126.49K
– 370.5K 1.77M – –
10.54M 12.24M 3.94M 854.15K 138.13K
– -4.34M 1.64M – –
– – – – –
10.54M 12.24M 3.94M 854.15K 138.13K
– – – – –
31.65M 29.54M 29.61M 29.61M 29.61M
31.65M 29.54M 29.61M 29.61M 29.61M
-0.33 -0.56 -0.44 -0.03 0
-0.33 -0.56 -0.44 -0.03 0
-10.41M -7.86M -11.43M – –
-10.41M -12.19M -11.43M -854.15K -138.13K
– 4.34M – 854.15K 138.13K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.